Anke Richters

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer.

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer.

Journal: ESMO real world data and digital oncology

Published: April 03, 2026

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

Journal: European urology oncology

Published: December 18, 2025

Treatments and survival outcomes of patients with synchronous and metachronous metastatic bladder cancer: A population-based nationwide cohort study.

Treatments and survival outcomes of patients with synchronous and metachronous metastatic bladder cancer: A population-based nationwide cohort study.

Journal: Cancer treatment and research communications

Published: November 03, 2025

Disparities in cancer incidence and stage at diagnosis between male and female patients in the Netherlands.

Disparities in cancer incidence and stage at diagnosis between male and female patients in the Netherlands.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 28, 2025

Biased associations between number of BCG instillations and outcome in non-muscle-invasive bladder cancer.

Biased associations between number of BCG instillations and outcome in non-muscle-invasive bladder cancer.

Journal: BJU international

Published: July 24, 2025

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort.

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort.

Journal: European urology open science

Published: January 17, 2025

Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045.

Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045.

Journal: Cancer treatment and research communications

Published: December 13, 2024

The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study.

The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study.

Journal: BJU international

Published: December 04, 2024

Guidelines versus real-world data in metastatic bladder cancer: A population-based study on first-line chemotherapy treatment patterns.

Guidelines versus real-world data in metastatic bladder cancer: A population-based study on first-line chemotherapy treatment patterns.

Journal: Urologic oncology

Published: May 29, 2024

Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort.

Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort.

Journal: European urology open science

Published: November 29, 2023

Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology-a survey of Swiss clinicians.

Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology-a survey of Swiss clinicians.

Journal: Cancer reports (Hoboken, N.J.)

Published: September 10, 2023

Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers: A Systematic Review.

Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers: A Systematic Review.

Journal: JAMA oncology

Published: June 08, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026